Shop gray market black market supplies
- FDA registered
- ISO 13485
- BBB Accredited A+
Shop at LAC Health
Direct comparison
Gray Market vs Black Market: Supply Buyers
Gray market vs black market: the 19 CFR 133.23 test for gray goods, the FDA counterfeit device definition, and questions for lab and medical supply buyers.
Written and maintained by CASRAI Editorial Board
Last updated
How do Gray market and Black market (counterfeit) compare side by side?
The table below compares Gray market and Black market (counterfeit) across 10 dimensions, from what it is to when to pick each.
Side-by-side comparison
| Dimension | Gray market | Black market (counterfeit) |
|---|---|---|
| What it is | A foreign-made article bearing a genuine trademark or trade name identical with, or substantially indistinguishable from, a US-owned mark, imported without the authorization of the US owner (19 CFR 133.23(a), restricted gray market articles). | A counterfeit device, as the FDA quotes the statutory definition: a device which, or the container, packaging, or labeling of which, without authorization, bears a trademark. |
| Is the trademark genuine? | Yes. The mark is genuine; the issue is the route into the US market. | No. The mark appears on the device, container, packaging or labeling without authorization. |
| What is unauthorized | The importation, not authorized by the US trademark owner. | The use of the trademark itself. |
| Same-ownership exception | The restriction does not apply where the mark was applied under a foreign owner who is the same as the US owner, or a parent or subsidiary of the US owner (19 CFR 133.23(d)(1)). | Not part of the counterfeit definition the FDA quotes. |
| Physical and material differences | 19 CFR 133.23 covers articles physically and materially different from those authorized by the US trademark owner; the term is defined by reference to 19 CFR 133.2(e), read that section for the test. | Not the test. The definition turns on the unauthorized trademark. |
| Labeling route | Under 19 CFR 133.23(b), a label reading "This product is not a product authorized by the United States trademark owner for importation" can be applied in close proximity to the trademark. | Not applicable. That labeling provision belongs to the gray market rules. |
| FDA requirements | A medical device is subject to the FDA's laws and regulations before, during, and after it is offered for sale, including when imported. If entry information does not match the FDA's records, the FDA may gather additional information or may detain the product. | The same FDA statement applies to any device offered for sale; counterfeit is a defined category in the statute the FDA quotes. |
| Prescription drugs (not devices or lab supplies) | Under the Drug Supply Chain Security Act, providers must purchase prescription drug products only from authorized trading partners, and the FDA tells providers to verify that a distributor is licensed in the state(s) where it does business. | Same FDA page: the authorized-trading-partner requirement and state license check apply to prescription drugs only. Do not extend them to devices or lab supplies. |
| Questions to put to a supplier | Is this lot imported with the US trademark owner's authorization? Does the packaging carry the 19 CFR 133.23(b) statement? Does the supplier state that the goods match the US-authorized version? | Does the trademark on the device, container, packaging and labeling have the trademark owner's authorization behind it? Can the supplier show where the goods came from? |
| When to pick each | A buyer who needs goods authorized by the US trademark owner should ask for that confirmation in writing and identify any gray market goods before ordering. This page does not recommend gray market purchasing. | Not a sourcing option. Rule it out: a counterfeit device is defined by an unauthorized trademark. |
Sources
- 19 CFR 133.23 (law.cornell.edu/cfr/text/19/133.23)
- FDA, Importing Medical Devices (fda.gov/industry/importing-fda-regulated-products/importing-medical-devices)
- FDA, letters to doctors who may have purchased counterfeit or unapproved prescription drugs (fda.gov/drugs/drug-supply-chain-integrity). All read 2026-11-03
- FDA, letters to doctors who may have purchased counterfeit or unapproved prescription drugs (fda.gov/drugs/drug-supply-chain-integrity). Read 2026-11-03
Ask CASRAI · free to try
Ask about Gray Market vs Black Market: Supply Buyers
2 free questions a day, no account.
An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.
Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.
Works on this site and inside Claude, Cursor and the AI tools you already use.
Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.
Common questions
Common questions about Gray market vs Black market (counterfeit)
Grey market vs black market: what is the difference?
+
Grey is the UK spelling of gray. A gray market product is genuine and bears a genuine trademark but was imported without the US trademark owner's authorization (19 CFR 133.23(a)). A black market counterfeit device has a trademark on it, or on its container, packaging or labeling, without authorization (FDA's statutory definition). Both turn on authorization, but one is about the import route and the other is about the mark itself.
Black market vs gray market: where do they overlap?
+
Both involve a lack of authorization, and both sit outside the manufacturer's authorized channel. The FDA states that a device is subject to its laws and regulations before, during, and after it is offered for sale, so a gray market device is not exempt from FDA requirements. A product that is only gray market is not the same as a counterfeit device under the definitions read here.







